Iosief Abraha, Cristina Cusi

Alcohol and Drug Misuse

A Cochrane Handbook

• Broschiertes Buch

Produktbeschreibung

There is constant pressure for clinicians to practise evidence-based medicine. Cochrane Reviews are an important source of the evidence which informs clinical decisions but can still require considerable time to read and digest. This Cochrane Handbook of Alcohol and Drug Misuse serves as a concise guide to the evidence base for relevant interventions, highlighting the key points of Cochrane reviews for the busy practitioner.

Each review is analysed in a structured format, starting with the question, a brief background and a summary answer, followed by the results presented in comprehensive and concise way. The authors then illustrate the value that the review adds to the current knowledge, the main methodological limitations of the included studies and finally the implications of the review's conclusions for future research.

Addiction to drugs and alcohol is an increasing problem that all clinicians have to deal with. This is especially true for medical and family specialists but more so for those dealing with psychiatric, psychological and social problems. The benefit of having the evidence underpinning the clinical approach to all aspects of this topic cannot be underestimated.

The book's comprehensive coverage of interventions provides an authoritative reference for all physicians working with these patients, from family practitioners to clinical specialists and psychiatric specialists. With addiction to drugs and alcohol an increasingly serious morbidity and public health issue, this book from the Cochrane Collaboration will find a wide audience.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Cochrane Book Series (CBS) .
• Verlag: Wiley & Sons
• 1. Auflage
• Seitenzahl: 168
• Erscheinungstermin: 1. Oktober 2012
• Englisch
• Abmessung: 216mm x 136mm x 10mm
• Gewicht: 194g
• ISBN-13: 9780470659694
• ISBN-10: 0470659696
• Artikelnr.: 35941251

Autorenporträt

Iosief Abraha MD and Cristina Cusi MD are reviewers in the Cochrane Neurological Network based in Italy. They have carried out Cochrane reviews in a wide range of areas within the Cochrane review groups and specialised in reviewing drug and alcohol withdrawal treatments

Inhaltsangabe

Foreword, ix
Preface, xi
Acknowledgements, xii
Part 1: Alcohol
Psychosocial interventions
Chapter 1: Effectiveness of brief alcohol interventions in primary care
populations, 1
Chapter 2: Brief interventions for heavy alcohol users admitted to general
hospital wards, 5
Chapter 3: Alcoholics Anonymous and other 12-step programmes for alcohol
dependence, 8
Chapter 4: Mentoring adolescents to prevent substance use disorders, 10
Chapter 5: Universal school-based prevention programmes for alcohol misuse
in young people, 12
Chapter 6: Universal multicomponent prevention programmes for alcohol
misuse in young people, 15
Chapter 7: Universal family-based prevention programmes for alcohol misuse
in young people, 17
Chapter 8: Social norms interventions to reduce alcohol misuse in
university or college students, 19
Chapter 9: Psychosocial interventions for women enrolled in alcohol
treatment during pregnancy, 22
Pharmacological interventions
Chapter 10: Benzodiazepines for alcohol withdrawal, 24
Chapter 11: Anticonvulsants for alcohol withdrawal, 27
Chapter 12: Acamprosate for alcohol dependence, 31
Chapter 13: Baclofen for alcohol withdrawal, 34
Chapter 14: Gamma-hydroxybutyrate for treatment of alcohol withdrawal and
prevention of relapse, 36
Chapter 15: Psychotropic analgesic nitrous oxide for alcohol withdrawal, 40
Chapter 16: Efficacy and safety of pharmacological interventions for the
treatment of alcohol withdrawal, 43
Chapter 17: Opioid antagonists for alcohol dependence, 46
Chapter 18: Pharmacologic interventions for pregnant women enrolled in
alcohol treatment, 49
Part 2: Drugs
Psychosocial interventions
Chapter 19: School-based prevention for illicit substance use disorders, 51
Chapter 20: Interventions for prevention of substance use disorders by
young people delivered in non-school settings, 54
Chapter 21: Case management for persons with substance use disorders, 56
Chapter 22: Motivational interviewing for substance use disorders, 59
Chapter 23: Therapeutic communities for substance use disorders, 62
Chapter 24: Interventions for drug-using offenders in the courts, secure
establishments and the community, 64
Chapter 25: Psychosocial interventions for pregnant women in outpatient
illicit drug treatment programmes compared to other interventions, 67
Cocaine dependence
Chapter 26 Psychosocial interventions for cocaine and psychostimulant
amphetamine related disorders, 69
Chapter 27: Antidepressants for cocaine dependence, 71
Chapter 28: Antipsychotic medications for cocaine dependence, 74
Chapter 29: Anticonvulsants for cocaine dependence, 76
Chapter 30: Dopamine agonists for cocaine dependence, 78
Chapter 31: Disulfiram for the treatment of cocaine dependence, 82
Chapter 32: Efficacy of psychostimulant drugs for cocaine dependence, 84
Chapter 33: Auricular acupuncture for cocaine dependence, 87
Chapter 34: Psychosocial treatment for opiate dependence, 89
Chapter 35: Psychosocial and pharmacological treatments versus
pharmacological treatments for opioid detoxification, 91
Chapter 36: Psychosocial combined with agonist maintenance treatments
versus agonist maintenance treatments alone for treatment of opioid
dependence, 94
Chapter 37: Alpha withdrawal, 96
Chapter 38: Buprenorphine for the management of opioid withdrawal, 99
Chapter 39: Buprenorphine maintenance versus placebo or methadone
maintenance for opioid dependence, 102
Chapter 40: Methadone at tapered doses for the management of opioid
withdrawal, 105
Chapter 41: Methadone maintenance at different dosages for opioid
dependence, 108
Chapter 42: Methadone maintenance therapy versus no opioid replacement
therapy for opioid dependence, 110
Chapter 43: Opioid antagonists under heavy sedation or anaesthesia for
opioid withdrawal, 113
Chapter 44: Opioid antagonists with minimal sedation for opioid withdrawal,
115
Chapter 45: Oral naltrexone maintenance treatment for opioid dependence,
118
Chapter 46: Sustained-release naltrexone for opioid dependence, 121
Chapter 47: Heroin maintenance for chronic heroin-dependent individuals,
123
Chapter 48: LAAM maintenance versus methadone maintenance for heroin
dependence, 126
Chapter 49: Detoxification treatments for opiate-dependent adolescents, 129
Chapter 50: Maintenance treatments for opiate-dependent adolescents, 131
Chapter 51: Maintenance agonist treatments for opiate-dependent pregnant
women, 133
Chapter 52: Pharmacological treatment for depression during opioid agonist
treatment for opioid dependence, 135
Chapter 53: Inpatient versus other settings for detoxification for opioid
dependence, 138
Chapter 54: Psychotherapeutic interventions for cannabis use or dependence
in outpatient settings, 140
Chapter 55: Pharmacological interventions for benzodiazepine
mono-dependence management in outpatient settings, 142
Chapter 56: Treatment for amphetamine dependence, 145
Chapter 57: Treatment for amphetamine withdrawal, 147
Chapter 58: Treatment for amphetamine psychosis, 149
Chapter 59: Treatment for methaqualone dependence in adults, 151
Index, 153